A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients

Journal of the National Cancer Institute

Volumn 97, Issue 7, 2005, Pages 481-488

  Bairati, Isabelle ^a   Meyer, François ^a   Gélinas, Michel ^c   Fortin, André ^b   Nabid, Abdenour ^d   Brochet, François ^e   Mercier, Jean Philippe ^f   Têtu, Bernard ^a   Harel, François ^a   Mâsse, Benoît ^g   Vigneault, Eric ^b   Vass, Sylvie ^e   del Vecchio, Pierre ^c   Roy, Jean ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^e Centre Hospitalier de la Sagamie   (Canada)

^f MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^g Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; MINERAL; PLACEBO; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; ENDOCRINE DISEASE; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GASTROINTESTINAL DISEASE; HEAD AND NECK CANCER; HUMAN; KAPLAN MEIER METHOD; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC DISEASE; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SECOND CANCER; SKIN DISCOLORATION; SKIN DISEASE; UROGENITAL TRACT DISEASE; VITAMIN SUPPLEMENTATION; AGED; DRUG ADMINISTRATION; EPIDEMIOLOGY; HEAD AND NECK TUMOR; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RADIATION INJURY; RADIOTHERAPY; RISK; SURVIVAL; TREATMENT FAILURE; TUMOR RECURRENCE;

ADULT; AGED; ALPHA-TOCOPHEROL; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BETA CAROTENE; CONFOUNDING FACTORS (EPIDEMIOLOGY); DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 15944375455     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji095     Document Type: Article

References (35)

1. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 1991;2:325-57.
2. American Institute for Cancer Research/World Cancer Research Fund. Food, nutrition and the prevention of cancer: a global perspective. Washington (DC): American Institute for Cancer Research; 1997.
3. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92.
4. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
5. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effect of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-42.
6. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
7. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
8. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994;12:851-73.
9. National Cancer Institute of Canada. Canadian cancer statistics 2004. Toronto, Canada, 2004.
10. Million RR, Cassisi NJ, Clark JR. Cancer of the head and neck. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer, principles & practice of oncology. Philadelphia (PA): JB Lippincott Company; 1989. p. 488-590.
11. Cooper JS, Pajak TF, Rubin P, Tupchong L, Brady LW, Leibel SA, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989;17:449-56.
12. McDonald S, Haie C, Rubin P, Nelson D, Divers LD. Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment, and prevention. Int J Radiat Oncol Biol Phys 1989;17:457-65.
13. Bairati I, Brochet F, Roy J, Gélinas M, Nabid A, Tetu B, et al. Prévention des seconds cancers par supplémentation vitaminique chez les patients traités pour un premier cancer ORL. Bull Cancer Radiother 1996;83:12-6.
14. Mayne ST, Cartmel B, Baum M, Shor-Posner G, Fallon BG, Briskin K, et al. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer. Cancer Res 2001;61:1457-63.
15. Toma S, Bonelli L, Sartoris A, Mira E, Antonelli A, Beatrice F, et al. Beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial. Oncol Rep 2003;10:1895-901.
16. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of chemotherapeutic agents. New York (NY): Columbia Press; 1949. p. 191-205.
17. Prasad KN, Kumar A, Kochupillai V, Cole WC. High doses of multiple anti-oxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 1999;18:13-25.
18. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia (PA): J.B. Lippincott Company; 1993.
19. National Cancer Institute of Canada Clinical Trial Group. NCIC common toxicity criteria (CTC) grading system. In: Cassidy J, Bissett D, Spence R, editors. Oxford handbook of oncology. Appendix 1. London (United Kingdom): Oxford University Press; 2002.
20. Miller KW, Lorr NAS, Yang CS. Simultaneous determination of plasma retinol, alpha-tocopherol, lycopene, alpha-carotene, and beta-carotene by high-performance liquid chromatography. Anal Biochem 1984;138:340-5.
21. Catignani GL, Bieri JG. Simultaneous determination of retinol and α-tocopherol in serum or plasma by liquid chromatography. Clin Chem 1983;29:708-12.
22. Gridley G, McLaughlin JK, Block G, Blot WJ, Gluch M, Fraumeni JF Jr. Vitamin supplement use and reduced risk of oral and pharyngeal cancer. Am J Epidemiol 1992;135:1083-92.
23. Warren S, Gates O. Multiple primary malignant tumors: A survey of the literature and a statistical study. Am J Cancer 1932;16:1358-414.
24. Lefor AT, Bredenberg CE, Kellman RM, Aust JC. Multiple malignancies of the lung and head and neck. Second primary tumor or metastasis? Arch Surg 1986;121:265-70.
25. Hong WK, Lippman SM, Itris LM, Karp DD, Lee JS, Byers RM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
26. EGRET SIZ. A program for sample size and power estimation. Reference manual. Seattle (WA): Statistics and Epidemiology Research Corporation; 1993.
27. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York (NY): Springer-Verlag; 2000.
28. Collett D. Modelling survival data in medical research. Boca Raton (FL): CRC Press; 2003.
29. Machlin LJ, Gabriel E. Kinetics of tissue alpha-tocopherol uptake and depletion following administration of high levels of vitamin E. Ann N Y Acad Sci 1982;393:48-60.
30. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, Albanes D, Taylor PR, Albert P, the ATBC Study Group. Incidence of cancer and mortality following α-tocopherol and β-carotene supplementation: a postintervention follow-up. JAMA 2003; 290:476-85.
31. Christen WG, Gaziano JM, Hennekens CH. Design of Physicians' Health Study II - a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of the results of completed trials. Ann Epidermiol 2000;10:125-34.
32. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. β-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999;91:2102-6.
33. Hoque A, Albanes D, Lippman SM, Spitz MR, Taylor PR, Klein EA, et al. Molecular epidermiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control 2001;12:627-33.
34. Prasad KN, Cole WC, Kumar B, Prasad KC. Pros and cons of antioxidant use during radiation therapy. Cancer Treat Rev 2002;28:79-91.
35. Seifried HE, McDonald SS, Anderson DE, Greenwald P, Milner JA. The antioxidant conundrum in cancer. Cancer Res 2003;63:4295-8.